POPART`MUS
What it found
No result yet.
What was tested
Treatment tested
- Estradiol
Estrogen receptor alpha agonist
- Nomegestrol acetate
Progesterone receptor agonist
What it measured
Main measures
The primary endpoint is to compare the rate of relapses during the dirst 12 weeks after delivery, between the treated and placebo groups
Relapses
Who could take part
MS (type not specified)
Inclusion: - Multiple sclerosis according to Mac Donald criteria (including clinically syndromes fulfilling MRI Exclusion: - Age < 18 years
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
to test the hypothesis that a progestin given soon after delivery together with low doses estradiol prevent relapses in the first post partum trimester in parturing women with multiple sclerosis
Loading reviews and guidelines…
Related trials
- Multiple Sclerosis, menopause and hormone replacement the…
Phase 4 · Completed
No result found
- Oral Testosterone for Fatigue in Male Multiple Sclerosis …
Phase 2 · Stopped early
Stopped early
- A Trial to Investigate the Effectiveness of Testosterone …
Phase 2 · Withdrawn
Stopped early
History
Started
Oct 2008
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error